Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia

Monique Terwijn1, Wendelien Zeijlemaker1, Angèle Kelder1

  • 1Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.

Plos One
|September 23, 2014
PubMed
Abstract

Related Concept Videos